Psoriasis is considered one of the most prevalent immune-mediated inflammatory diseases, which leads to physical and emotional disabilities that can severely impact patients' quality of life. Phototherapy with ultraviolet (UV) radiation has been an effective treatment for psoriasis for well over 85 years. Home phototherapy is becoming more popular as several factors act as a barrier for outpatient phototherapy for moderate to severe psoriasis.
Various studies have shown home phototherapy to be an effective and safe option. Today, many phototherapy units are available for home use. In this article, we will review the efficacy and safety of home phototherapy and briefly discuss the available home phototherapy units, including handheld units for scalp psoriasis and psoriasis limited to smaller body surface area.
Johnson-HuangL.M., Suárez-FariñasM., Sullivan-WhalenM.Effective narrow-band UVB radiation therapy suppresses the IL-23/IL-17 axis in normalized psoriasis plaques. J Invest Dermatol.2010; 130(11): 2654–63.
2.
GoeckermanW.H. (1925). The treatment of psoriasis. Northwest Med.24, 229–231.
3.
DiffeyB.L., FarrP.M., IveF.A.Home phototherapy of solar urticaria: a case report. Photodermatol1984; Jun; 1(3): 145–6.
4.
HaykalK.A., DesGroseilliersJ.P.Are narrow-band ultraviolet B home units a viable option for continuous or maintenance therapy of photoresponsive diseases?J Cutan Med Surg.2006; Sep-Oct; 10(5): 234–40.
5.
FeldmanS.R., ClarkA., ReboussinD.M., FleischerA.B.An assessment of potential problems of home phototherapy treatment of psoriasis. Cutis.1996 Jul;58(1): 71–3.
6.
KruegerJ.G., WolfeJ.T., NabeyaR.T.Successful ultraviolet B treatment of psoriasis is accompanied by a reversal of keratinocyte pathology and by selective depletion of intraepidermal T cells, J. Exp. Med.1995; 182: 2057–2068.
7.
CarrascosaJ.M., TapiaG., BielsaI.Effects of narrowband UV-B onpharmacodynamic markers of response to therapy: an immunohistochemical study over sequential samples. J Cutan Pathol.2007; 34: 769–76.
8.
TjioeM., SmitsT.The differential effect of broad band vs narrow band UVB with respect to photodamage and cutaneous inflammation. Exp Dermatol.2003; 12: 729–33.
9.
WaltersI.B., OzawaM., CardinaleI.Narrowband (312-nm) UV-B suppresses interferon gamma and interleukin (IL) 12 and increases IL-4 transcript: differential regulation of cytokines at the single-cell level. Arch Dermatol.2003; 139: 155–61.
10.
PiskinG., KoomenC.W., PicavetD.Ultraviolet-B irradiation decreases IFN-gamma and increases IL-4 expression in psoriatic lesional skin in situ and in cultured dermal T cells derived from these lesions. Exp Dermatol.2003; 12: 172–80.
11.
ParrishJ.A.Treatment of psoriasis with long-wave ultraviolet light. Arch Dermatol.1977; Nov 113(11): 1525–8.
12.
PetrozziJ.W., BartonJ.O., KaidbeyK.K.Updating the Goeckerman regimen for psoriasis. Br J Dermatol.1978 Apr;98(4): 437–44.
Le VineM.J., WhiteH.A., ParrishJ.A.Components of the Goeckerman regimen. J Invest Dermatol.1979 Aug;73(2): 170–3.
15.
BoerJ., SchothorstA.A., SuurmondD.UV-B phototherapy of psoriasis. Dermatologica.1980; 161(4): 250–8.
16.
AdrianR.M., ParrishJ.A., MomtazT.Outpatient phototherapy for psoriasis. Arch Dermatol.1981 Oct;117(10): 623–6.
17.
ParrishJ.A., JaenickeK.F.Action spectrum for phototherapy of psoriasis. J Invest Dermatol.1981 May;76(5): 359–62.
18.
ReynoldsN.J., FranklinV., GrayJ.C., DiffeyB.L., FarrP.M.Narrow-band ultraviolet B and broad-band ultraviolet A phototherapy in adult atopic eczema: a randomised controlled trial. Lancet.2001 Jun 23; 357(9273): 2012–6.
19.
HamzaviI., JainH., McLeanD.Parametric modeling of narrowband UV-B phototherapy for vitiligo using a novel quantitative tool: the Vitiligo Area Scoring Index. Arch Dermatol.2004 Jun;140(6): 677–83.
20.
GathersR.C., ScherschunL., MalickF.Narrowband UVB phototherapy for early-stage mycosis fungoides. J Am Acad Dermatol.2002 Aug;47(2): 191–7.
21.
WaltersI.B., BurackL.H., CovenT.R., GilleaudeauP., KruegerJ.G.Suberythemogenic narrow-band UVB is markedly more effective than conventional UVB in treatment of psoriasis vulgaris. J Am Acad Dermatol.1999 Jun;40(6 Pt 1): 893–900.
22.
SnellmanE., KlimenkoT., RantanenT.Randomized half-side comparison of narrowband UVB and trimethylpsoralen bath plus UVA treatments for psoriasis. Acta Derm Venereol.2004; 84(2): 132–7.
23.
FowlerJ.F., DuhM.S., RovbaL.The impact of psoriasis on health care costs and patient work loss. J Am Acad Dermatol.2008; 59(5): 772–80.
24.
FeldmanS.R., GartonR., AverettW.Strategy to manage the treatment of severe psoriasis: considerations of efficacy, safety and cost. Expert Opin Pharmacother.2003; 4(9): 1525–32.
JordanW.P.Jr., ClarkeA.M., HaleR.K.Long-term modified Goeckerman regimen for psoriasis using an ultraviolet B light source in the home. J Am Acad Dermatol.1981 May; 4(5): 584–91.
27.
KoekM.B., BuskensE., van WeeldenH.Home versus outpatient ultraviolet B phototherapy for mild to severe psoriasis: pragmatic multicenter randomized controlled non-inferiority trial (PLUTO study). BMJ.2009, 338: b1542.
28.
TollA., Velez-GonzalezM., GallardoF.Treatment of localized persistent plaque psoriasis with incoherent narrowband ultraviolet B phototherapy. J Dermatolog Treat.2005; 16: 165–8.
29.
LapidothM., AdattoM., DavidM.Targeted UVB phototherapy for psoriasis: a preliminary study. Clin Exp Dermatol.2007; 32: 642–5.
30.
National Psoriasis Foundation. Accessed: March 2013.
31.
The Daalvin Company. Accessed: April 2013.
32.
Solarc Systems. Accessed: March 2013.
33.
Psoralite. Accessed: March 2013.
34.
Richmond Light. Accessed: March 2013.
35.
UVBioTek. Accessed: March 2013.
36.
National Biological Corp. Accessed: April, 2013.
37.
SchneiderL.A., HinrichsR., Scharffetter-KochanekK.Phototherapy and photochemotherapy. Clin Dermatol.2008 Sep;26(5): 464–76.
38.
LuiH.Phototherapy of psoriasis: update with practical pearls. J Cutan Med Surg.2002 May;6(3 Suppl): 17–21.
39.
CameronH., YuleS., MoseleyH.Taking treatment to the patient: development of a home TL-01 ultraviolet B phototherapy service. Br J Dermatol.2002 Nov;147(5): 957–65.
